Entero Healthcar, a company in the Pharmacy Retail industry, reported revenue of ₹2,087 crore and net profit of ₹61 crore for the September 2026 quarter.
Entero Healthcar (NSE: ENTERO) closed at ₹1,901.80 on 20 Nov 2026, up 77.7% over the past year. Its market capitalisation is ₹8,285 crore and it trades at 57.9 times earnings.
Incorporated in 2018, Entero Healthcare Solutions Ltd is in the business of distribution and marketing of pharmaceutical and surgical products and allied services
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.